User profiles for Walid F Gellad
Walid GelladUniversity of Pittsburgh, VA, RAND Verified email at rand.org Cited by 9317 |
A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity
Background Medication nonadherence is a common problem among the elderly. Objective
To conduct a systematic review of the published literature describing potential nonfinancial …
To conduct a systematic review of the published literature describing potential nonfinancial …
Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis
…, M Maglione, EA McGlynn, WF Gellad - Journal of general …, 2011 - Springer
Objective To conduct a meta-analysis of the association between depression and medication
adherence among patients with chronic diseases. Poor medication adherence may result …
adherence among patients with chronic diseases. Poor medication adherence may result …
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Objective To evaluate whether early initiation of prophylactic anticoagulation compared with
no anticoagulation was associated with decreased risk of death among patients admitted to …
no anticoagulation was associated with decreased risk of death among patients admitted to …
Comparative effectiveness of pharmacologic treatments to prevent fractures: an updated systematic review
Background: Osteoporosis is a major contributor to the propensity to fracture among older
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …
adults, and various pharmaceuticals are available to treat it. Purpose: To update a review …
Medication adherence to multidrug regimens
Older adults are the largest consumers of medication in the United States, largely because
of an age-associated increase in chronic conditions. 1 Because of this, multiple medication …
of an age-associated increase in chronic conditions. 1 Because of this, multiple medication …
A policy prescription for reducing health disparities—achieving pharmacoequity
In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on
retail prescription drugs alone. 1 Onaverage, individualsintheUSspendmorethan $1100 per …
retail prescription drugs alone. 1 Onaverage, individualsintheUSspendmorethan $1100 per …
Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs
Over the past 15 years, more than 165 000 people in the United States have died from
overdoses related to prescription opioids, 1 and millions more have suffered adverse …
overdoses related to prescription opioids, 1 and millions more have suffered adverse …
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study
WF Gellad, JS Haas, DG Safran - Journal of general internal medicine, 2007 - Springer
BACKGROUND Nonadherence to prescription drugs results in poorer control of chronic
health conditions. Because of significant racial/ethnic disparities in the control of many chronic …
health conditions. Because of significant racial/ethnic disparities in the control of many chronic …
Evaluation of machine-learning algorithms for predicting opioid overdose risk among medicare beneficiaries with opioid prescriptions
Importance Current approaches to identifying individuals at high risk for opioid overdose target
many patients who are not truly at high risk. Objective To develop and validate a machine-…
many patients who are not truly at high risk. Objective To develop and validate a machine-…
Effectiveness and safety of non–vitamin K antagonist oral anticoagulants for atrial fibrillation and venous thromboembolism: a systematic review and meta-analyses
Purpose The findings from the observational studies comparing the effectiveness and safety
of non–vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (…
of non–vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (…